mva-nsmut
Vaccineexperimental
Clinical trial activity
5 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2010 (NCT01296451)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatitis C virusImmunity, active
Hepatitis C virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva-nsmut
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02568332 | Phase 1 | Jun 1, 2015 | Cantonal Hospital of St. Gallen, GlaxoSmithKline, ReiThera Srl, St. James's Hospital, Dublin, Trinity College Dublin, University of Oxford |
| NCT02362217 | Phase 1 | Oct 1, 2014 | GlaxoSmithKline, ReiThera Srl, University of Oxford |
| NCT01436357 | Phase 1/Phase 2 (Phase 2) | Mar 6, 2012 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01701336 | Phase 1 | Mar 1, 2012 | European Commission, ReiThera Srl |
| NCT01296451 | Phase 1 | Dec 1, 2010 | ReiThera Srl, University of Birmingham, University of Oxford, Wycombe Hospital, High Wycombe, Buckinghamshire |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ReiThera Srl | For profit | 4 | 2 | 1 | 2010 |
| University of Oxford | Academic/Hospital | 3 | 2 | 1 | 2010 |
| GlaxoSmithKline | For profit | 2 | 0 | 1 | 2014 |
| Cantonal Hospital of St. Gallen | Academic/Hospital | 1 | 0 | 1 | 2015 |
| European Commission | Government | 1 | 0 | 1 | 2012 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2012 |
| St. James's Hospital, Dublin | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Trinity College Dublin | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Birmingham | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Wycombe Hospital, High Wycombe, Buckinghamshire | Academic/Hospital | 1 | 0 | 1 | 2010 |
10 organizations
Page 1 / 1